CO18 Reuse of Tumor Necrosis Factor Inhibitors for Treatment of Rheumatoid Arthritis Despite Discordance with Patient-Important Outcomes and Standard Disease Assessments

Autor: Frick, A., Broestl, J., Cox, K., Milligan, K., Persons, D., Milligan, S.
Zdroj: In Value in Health June 2023 26(6) Supplement:S17-S17
Databáze: ScienceDirect